Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “neutral” rating and issued a $5.00 price objective on shares of Minerva Neurosciences in a report on Wednesday, February 26th. […]
StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “neutral” rating and issued a $5.00 price objective on shares of Minerva Neurosciences in a report on Wednesday, February 26th. […]
